Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,300.94
    +834.17 (+1.31%)
     

  • CMC Crypto 200

    1,386.49
    +73.86 (+5.63%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • Dow

    37,986.40
    +211.02 (+0.56%)
     

  • Nasdaq

    15,282.01
    -319.49 (-2.05%)
     

  • Gold

    2,406.70
    +8.70 (+0.36%)
     

  • Crude Oil

    83.24
    +0.51 (+0.62%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017

CapitalCube
Updated
ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017

Categories: Yahoo Finance Get free summary analysis ANI Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of ANI Pharmaceuticals, Inc. – Jazz Pharmaceuticals Plc, Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Lannett Company, Inc. and Pfizer Inc. (JAZZ-US, MYL-US, TEVA-US, LCI-US and PFE-US) that ... Read more (Read more...)

Continue reading